India’s largest Biotechnology Company and Global Biomarker leader partnered with IMC to conduct market research study to characterize the market potential of biomarker development and biomarker testing services, specifically in the areas of proteomics and metabolomics. The sponsor was exclusively interested in biomarkers measureable in plasma and serum, not molecular markers such as genetics based markers.
Solution
The project involved telephonic interviews, online survey and personal interview with heads of Clinical Development or Business development at top 50 Indian pharma/biotech companies, central labs and CROs engaged in clinical development of novel drugs.